Fisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares
** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39 ** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34 ** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption ** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co ** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55
Recent news on Fisher & Paykel Healthcare
See all newsFisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares
NZ's Fisher & Paykel falls on flagging cost blowout under new US tariff plan
Fisher & Paykel Healthcare hits over 2-year high on FY results, outlook
Fisher & Paykel Healthcare's Australian shares fall on device recall
NZ's Fisher & Paykel Healthcare eyes worst day in 2 years on bleak FY results